Healthycrop.world ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  18.1% 13.7% 25.9% 3.0% 1.4%  
Credit score (0-100)  9 16 2 57 76  
Credit rating  B BB B BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 95.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  60 0 0 0 0  
Gross profit  60.3 9.6 492 236 1,041  
EBITDA  60.3 9.6 492 186 643  
EBIT  60.3 9.6 492 186 643  
Pre-tax profit (PTP)  55.3 5.8 484.1 162.2 679.1  
Net earnings  43.1 4.5 377.5 148.2 546.8  
Pre-tax profit without non-rec. items  55.3 5.8 484 162 679  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  93.1 97.7 2,475 2,623 10,293  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  105 98.9 2,603 2,789 11,115  

Net Debt  -105 -98.9 -2,587 -2,239 -7,966  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  60 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  60.3 9.6 492 236 1,041  
Gross profit growth  0.0% -84.1% 5,040.4% -52.1% 341.9%  
Employees  0 0 0 1 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 200.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  105 99 2,603 2,789 11,115  
Balance sheet change%  0.0% -6.0% 2,531.0% 7.1% 298.6%  
Added value  60.3 9.6 491.9 186.5 642.8  
Added value %  99.9% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 344 1,973  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  99.9% 0.0% 0.0% 0.0% 0.0%  
EBIT %  99.9% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 79.1% 61.7%  
Net Earnings %  71.4% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  71.4% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  91.6% 0.0% 0.0% 0.0% 0.0%  
ROA %  57.3% 9.4% 36.4% 6.9% 9.8%  
ROI %  64.8% 10.0% 38.2% 7.2% 10.1%  
ROE %  46.3% 4.7% 29.3% 5.8% 8.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  88.4% 98.7% 95.1% 94.1% 92.6%  
Relative indebtedness %  20.1% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -154.2% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -174.5% -1,033.8% -525.9% -1,200.6% -1,239.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  8.7 77.5 20.4 32.3 27.9  
Current Ratio  8.7 77.5 20.4 32.3 27.9  
Cash and cash equivalent  105.3 98.9 2,586.7 2,238.6 7,966.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  174.4% 0.0% 0.0% 0.0% 0.0%  
Net working capital  93.1 97.7 2,475.2 2,369.2 8,477.8  
Net working capital %  154.2% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 186 214  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 186 214  
EBIT / employee  0 0 0 186 214  
Net earnings / employee  0 0 0 148 182